Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Rédini

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2012
Proteoglycans: complex diversity in structure and functionsFrançoise Rédini
Frontiers in Oncology|May 16, 2018
Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their MicroenvironmentFranck Verrecchia, Françoise Rédini
Bonekey Reports|January 15, 2014
Targeted therapies for bone sarcomasDominique Heymann, Françoise Rédini
Cytokine & Growth Factor Reviews|December 19, 2002
Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disordersEva Grimaud, Dominique Heymann, Françoise Rédini
American Journal of Cancer Research|December 30, 2011
TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironmentGaëlle Picarda, Valérie Trichet, Stéphane Téletchéa, et al.
Cells|March 1, 2020
SHH Signaling Pathway Drives Pediatric Bone Sarcoma ProgressionFrédéric Lézot, Isabelle Corre, Sarah Morice, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 11, 2007
Proteoglycans: key partners in bone cell biologyFrançois Lamoureux, Marc Baud'huin, Laurence Duplomb, et al.
Biomolecules|August 30, 2020
Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone TumorsJulie Talbot, Maryne Dupuy, Sarah Morice, et al.
Oncology Reports|February 9, 2006
Osteosarcoma: current status of immunotherapy and future trends (Review)Kanji Mori, Françoise Rédini, François Gouin, et al.
Trends in Molecular Medicine|July 10, 2004
Bisphosphonates: new therapeutic agents for the treatment of bone tumorsDominique Heymann, Benjamin Ory, François Gouin, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2012
Proteoglycans: complex diversity in structure and functionsFrançoise Rédini
Frontiers in Oncology|May 16, 2018
Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their MicroenvironmentFranck Verrecchia, Françoise Rédini
Bonekey Reports|January 15, 2014
Targeted therapies for bone sarcomasDominique Heymann, Françoise Rédini
Cytokine & Growth Factor Reviews|December 19, 2002
Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disordersEva Grimaud, Dominique Heymann, Françoise Rédini
American Journal of Cancer Research|December 30, 2011
TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironmentGaëlle Picarda, Valérie Trichet, Stéphane Téletchéa, et al.
Cells|March 1, 2020
SHH Signaling Pathway Drives Pediatric Bone Sarcoma ProgressionFrédéric Lézot, Isabelle Corre, Sarah Morice, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 11, 2007
Proteoglycans: key partners in bone cell biologyFrançois Lamoureux, Marc Baud'huin, Laurence Duplomb, et al.
Biomolecules|August 30, 2020
Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone TumorsJulie Talbot, Maryne Dupuy, Sarah Morice, et al.
Oncology Reports|February 9, 2006
Osteosarcoma: current status of immunotherapy and future trends (Review)Kanji Mori, Françoise Rédini, François Gouin, et al.
Trends in Molecular Medicine|July 10, 2004
Bisphosphonates: new therapeutic agents for the treatment of bone tumorsDominique Heymann, Benjamin Ory, François Gouin, et al.
Pageof 7